Con l’evolvere delle conoscenze sul SARS-CoV-2 aumentano anche le risorse disponibili per un aggiornamento scientifico e professionale. Qui elenchiamo alcuni dei principali riferimenti specifici per l’ematologia.

 

Enti regolatori

FDA https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-and-emerging-threats/coronavirus-disease-2019-covid-19

EMA https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19

AIFA https://www.aifa.gov.it/emergenza-covid-19

 

Società Scientifiche

ASH https://www.hematology.org/covid-19

EHA https://ehaweb.org/covid-19/

SIE http://www.siematologia.it/

ISTH ISTH International Society on Thrombosis and Hemostasis

IMS   https://www.myelomasociety.org/

EuroBoodNet   https://eurobloodnet.eu/covid-19/

Histiocyte Society   https://www.histio.org/covid19

Fondazione Progetto Ematologia   Raccomandazioni pratiche per il management dei pazienti con ITP durante l’emergenza COVID-19 (revisione gennaio 2021)

Editori e riviste

New England Journal of Medicine https://www.nejm.org/coronavirus 

The Lancet https://www.thelancet.com/coronavirus 

BJH Care of haematology patients in a COVID‐19 epidemic

Springer https://www.springernature.com/gp/researchers/campaigns/coronavirus

Elsevier https://www.elsevier.com/connect/coronavirus-information-center

Wiley https://novel-coronavirus.onlinelibrary.wiley.com/

Medrxiv (preprint server) https://www.medrxiv.org/

 

← Torna alla pagina di INSIEME